What the Original Article Reported
The linked article in The Hindu discusses how paediatricians in Hyderabad pursued, over eight years, legal and regulatory avenues, which culminated in the FSSAI (Food Safety and Standards Authority of India) issuing a directive prohibiting the use of the term “ORS” (Oral Rehydration Salts) on food products and beverage labels that do not comply with medically approved standards.
Some key points from that article:
- The campaign was led by Hyderabad-based paediatricians, especially Dr. Sivaranjani Santosh (also spelled Sivaranjini in some sources).
- Their contention: several commercial drinks and beverages had been using names or branding that included “ORS,” thereby misleading consumers (especially caregivers) into believing they were safe, medically effective rehydration solutions.
- Such misuse can be dangerous: a beverage with too much sugar or improperly balanced electrolytes can worsen dehydration or diarrhoea in children.
- The FSSAI order mandates that no food product may use “ORS” (whether standalone, with prefixes/suffixes, or as part of a brand/trademark) unless the product conforms to the WHO-recommended ORS formula.
- Earlier permissions allowing some qualified use of “ORS” (with disclaimers) have been withdrawn.
- The article also notes that this marks the culmination of years of advocacy, court petitions, and regulatory engagement by doctors and public interest actors.
Additional News & Coverage: Context, Reactions, and Implications
Here’s what subsequent reporting and commentary add to the picture:
1. What Exactly Was Banned & Why
- The FSSAI, in a directive dated October 14, 2025, ordered all food business operators to immediately stop using the term “ORS” on product names, labels, or trademarks, unless the product meets the WHO formulation standards. SCC Online+3Business Standard+3The Economic Times+3
- This includes use as prefix, suffix, or part of a brand name—even if earlier permissions allowed that use with disclaimers. Those earlier permissions (notably from July 2022 and February 2024) have now been withdrawn. India Today+3Business Standard+3The Economic Times+3
- The FSSAI considers use of “ORS” in such contexts as misleading, erroneous, ambiguous, or deceptive labeling, violating the Food Safety and Standards Act, 2006 and its labelling/advertising regulations. The Economic Times+3SCC Online+3India Today+3
- Violations may attract penalties under Sections 52 and 53 of the FSSAI Act (which deal with misbranding and misleading advertisement). Business Standard+2Business Standard+2
- The FSSAI has also directed state food safety commissioners and licensing authorities to enforce immediate compliance. The Economic Times+2India Today+2
2. How This Change Came About: The Role of Dr. Sivaranjani (or Sivaranjini) Santosh
- The campaign began approximately eight years ago. Several reports trace Dr. Santhosh’s early social-media posts, clinical experiences, and raising awareness among colleagues, parents, and regulatory bodies. India Today+3The Indian Express+3Firstpost+3
- In 2022, she filed a Public Interest Litigation (PIL) before the Telangana High Court, challenging the sale of drinks labeled as ORS but not complying with electrolyte/sugar standards. Telangana Today+4The News Minute+4The Indian Express+4
- Over time, the advocacy gained more visibility. Some of her posts or videos went viral, raising public and regulatory awareness. Firstpost+3Telangana Today+3India Today+3
- Dr. Santhosh has said that for many children she saw, they were already severely dehydrated despite being given “ORS-labeled” drinks from stores, indicating those drinks were ineffective (or worse). The News Minute+3The Indian Express+3India Today+3
- Upon the FSSAI’s order, she expressed emotional relief and called it a “people’s win” — not just a personal victory. She emphasized that children will now be better protected from misleading labels. Telangana Today+3India Today+3The Indian Express+3
3. Health Implications & Risks
- Why this matters: ORS (Oral Rehydration Solutions) are a globally accepted, simple, low-cost therapy for dehydration caused by diarrhoea. The WHO-recommended ORS formula has precise amounts of sodium, potassium, citrate, and glucose/dextrose. The News Minute+4Firstpost+4The Indian Express+4
- If a drink labeled “ORS” has excess sugar, inadequate electrolytes, or improper osmolarity, it may worsen dehydration or delay recovery. The News Minute+3The Indian Express+3Firstpost+3
- Some anecdotal cases: media reports mention children or patients who were given so-called ORS drinks which failed them, contributing to worsening condition and hospitalisation. The Indian Express+2Firstpost+2
- The risk is especially grave in infants, children, the elderly, or those already weak or malnourished.
4. Regulatory & Industry Impact
- Several beverage companies had been marketing drinks with names like “ORS-L,” “Rebalance ORS,” etc. These products now must rebrand, change labels, or drop such naming. India Today+4Business Standard+4Business Standard+4
- The FSSAI’s action signals a stricter stance on misleading health marketing claims in food products — distinguishing between legitimate medical claims and promotional exaggeration. Business Standard+4SCC Online+4India Today+4
- By rescinding previous relaxations (that allowed “ORS” usage with disclaimers), FSSAI is emphasizing that certain words (especially medically loaded ones) should not be used loosely in food branding. India Today+4Business Standard+4The Economic Times+4
- States and central licensing authorities are now tasked with enforcing compliance, inspecting labels, and penalizing violators. The Economic Times+1
5. Legal & Policy Observations
- Some legal analyses (e.g. SCC Online blog) note that the FSSAI’s order engages multiple legal provisions:
- Sections of the FSSAI Act dealing with misbranding/misleading representation
- Labelling & Display Regulations, 2020
- Advertising & Claims Regulations, 2018
- The order is seen as a regulatory correction to earlier permissiveness, reining in ambiguous brand naming. SCC Online
- The move also underscores a boundary between food products and medicinal/therapeutic products. ORS is considered therapeutic; food-based drinks should not appropriate that label unless they satisfy medical standards. Firstpost+3India Today+3SCC Online+3
- Several commentators regard this as a precedent for regulating other health-claim labels (e.g. “immunity,” “probiotic,” etc.) more carefully.
Summary (Brief)
After an eight-year advocacy driven by paediatrician Dr. Sivaranjani Santosh, the FSSAI has banned the use of the term “ORS” (oral rehydration salts) on any food or beverage product label, name, or trademark that does not conform to the WHO-recommended ORS formulation. Previous allowances that permitted “ORS” branding with disclaimers have been revoked. The FSSAI now considers usage of “ORS” in non-compliant products to be misleading, misbranded, and subject to penalties under the Food Safety and Standards Act, 2006. The move aims to protect consumers—especially children—from being misled by sugary drinks masquerading as therapeutic rehydration solutions.
Key Source Links for Further Reading
- Business Standard — “FSSAI bans use of ‘ORS’ on food labels, calls it misleading to consumers” Business Standard
- Deccan Chronicle — “FSSAI Bans Misuse of ORS Label After 8-year Long Battle” Deccan Chronicle
- Indian Express — “No more fake ORS, says food regulator after Hyderabad doctor’s 8-yr fight” The Indian Express
- Firstpost — “How a Hyderabad paediatrician waged 8-year battle to have ORS tags removed” Firstpost
- The News Minute — “Hyderabad paediatrician’s legal battle forces FSSAI to act against misuse of ORS label” The News Minute
- SCC Online — “FSSAI Bans Use of ‘ORS’ in Food Product Labeling” (legal commentary) SCC Online
- India Today — “FSSAI bans use of ORS on food and beverage products” India Today
- Telangana Today — “FSSAI bans misleading ‘ORS’ labels on beverages after Hyderabad doctor’s 8-year campaign” Telangana Today
🔬 How General Epidemiology Helps Solve This Problem
1. Identifying the Health Problem
Epidemiology begins with observation and case investigation:
- Paediatricians like Dr. Sivaranjani noticed a recurring pattern — children coming to hospitals severely dehydrated despite parents reporting that they gave “ORS” from the store.
- Epidemiological surveillance would note this as an aberrant trend — the expected protective behavior (ORS use) was not leading to recovery.
- Early epidemiologic insight: Something about the exposure (the product) was not truly providing therapeutic benefit.
2. Defining the Population and Exposure
- Epidemiologists define:
- Population: children (especially under 5) presenting with diarrhoeal dehydration.
- Exposure: consumption of beverages branded as “ORS” but non-medical.
- Outcome: dehydration not corrected or worsened despite “ORS” intake.
- Through descriptive epidemiology, trends by age, place, and time are analyzed — e.g., clusters of such cases in Hyderabad, patterns of use of misleading products, etc.
3. Conducting Analytical Studies
Epidemiologists could then use:
- Case–control studies — comparing children who used fake “ORS” and got worse vs. those who used standard WHO-ORS and recovered.
- Cohort studies — tracking outcomes among families using different hydration methods.
- Chemical or biochemical surveillance — lab analysis of the so-called ORS drinks to assess electrolyte composition.
Findings might show that the mislabeled drinks lack proper sodium and potassium, or contain excessive sugar, explaining adverse outcomes — epidemiological evidence linking the exposure to the health effect.
4. Quantifying the Risk
- Epidemiology quantifies risk ratios, attributable fractions, and population-attributable risks — e.g.: “Children consuming non-standard ‘ORS’ drinks were 3× more likely to remain dehydrated after 6 hours of treatment.”
- These data provide solid evidence for policy intervention — proving harm at population level, not just anecdotal cases.
5. Informing Public Health Policy and Regulation
- Once epidemiologic studies establish the link, the findings support public health action — in this case, FSSAI’s regulatory ban.
- Epidemiology provides:
- Scientific justification for the policy (e.g., misbranded products cause measurable harm).
- Risk communication frameworks — how to inform the public clearly.
- Evaluation methods — monitoring post-intervention outcomes (e.g., fewer dehydration complications after the ban).
6. Monitoring and Evaluation Post-Intervention
After the FSSAI order:
- Epidemiologists can track hospital admissions for dehydration to see if cases decline.
- They can monitor consumer awareness, labeling compliance, and recurrence of misleading marketing.
- This feedback loop ensures the policy is effective and adjusts if new risks arise.
📊 Broader Epidemiological Lessons from the Case
| Epidemiological Function | Role in the ORS Label Case |
|---|---|
| Surveillance | Detecting abnormal trends in dehydration cases. |
| Investigation | Identifying fake ORS brands and correlating with poor outcomes. |
| Data Analysis | Measuring association between mislabeled drinks and dehydration severity. |
| Risk Assessment | Quantifying harm and informing regulatory urgency. |
| Public Health Action | Providing evidence base for FSSAI’s labeling ban. |
| Health Education | Guiding doctors and public on proper ORS composition and safe use. |
| Evaluation | Measuring impact of the ban on child morbidity and mortality. |
🩺 Example: WHO’s Epidemiological View
Globally, WHO and UNICEF use epidemiological data to:
- Define the standard ORS formulation (based on global diarrhoeal mortality data).
- Track ORS coverage and effectiveness in reducing child mortality.
- Such epidemiological findings over decades showed ORS could reduce mortality by up to 93% — but only when used correctly.
Hence, protecting its label through regulatory action aligns perfectly with epidemiological logic.
🧩 Conclusion
General Epidemiology plays a vital role in:
- Detecting misuse of medical terms in the food industry,
- Demonstrating public health impact with evidence, and
- Guiding data-driven regulatory decisions like the FSSAI’s “ORS” labeling ban.
This is an excellent real-world example of how clinical observation, epidemiological investigation, and public health policy combine to prevent harm and safeguard community health.
🏥 General Epidemiology in Healthcare Management: Building Change-Makers through Doctorials Academy’s PGDHM Program
At Doctorials Academy, our Post Graduate Diploma in Hospital Management (PGDHM) is designed to create future-ready healthcare professionals — leaders who not only manage hospitals efficiently but also understand the science behind public health, disease trends, and preventive strategies.
One of the core subjects of the PGDHM curriculum is General Epidemiology, a foundation pillar of modern healthcare management. It equips students with the knowledge and analytical skills to understand how diseases spread, evaluate health programs, and influence public health policies with evidence-based decisions.
🔬 Why General Epidemiology Matters in Healthcare Management
Epidemiology is often described as the “science of public health decision-making.” It teaches how to use data, patterns, and population-level analysis to improve health outcomes — a vital skill not only for doctors but also for healthcare administrators and policy leaders.
In the context of healthcare management:
- It helps administrators identify emerging health threats early through data monitoring.
- Guides resource allocation during epidemics, hospital outbreaks, or community health crises.
- Provides the research tools to evaluate hospital performance, patient outcomes, and preventive health programs.
- Builds the ability to interpret public health data, understand clinical statistics, and apply research findings to real-world healthcare challenges.
Through case-based learning, students at Doctorials Academy study real examples — such as the recent FSSAI “ORS Label Ban”, where epidemiological evidence and data-based advocacy led to a national health regulation protecting millions of children.
Such case studies show how epidemiology extends far beyond hospitals — it shapes healthcare policy, regulation, and system-wide improvement.
🎓 About the PGDHM Program
The Post Graduate Diploma in Hospital Management (PGDHM) offered by Doctorials Academy, in academic collaboration with Medhavi Skill University (Government-recognized), is a comprehensive one-year program focused on bridging management principles with medical science.
🔑 Key Highlights:
- Duration: 1 Year | Mode: Online + Practical Learning
- Recognition: Offered in collaboration with Medhavi Skill University (UGC-approved)
- Eligibility: Open to graduates from Nursing, Pharmacy, Allied Health Sciences, and Management backgrounds
- Curriculum Focus:
- Hospital Administration & Operations
- Health Economics & Policy
- Medical Law & Ethics
- Healthcare Quality Management
- General Epidemiology & Research Methods
- Health Informatics & Digital Health
- Healthcare Marketing & HR Management
🧭 Learning Outcomes
Students completing PGDHM gain:
- Competence to analyze and interpret health data for effective management.
- Knowledge to design hospital-based research and public health projects.
- Skills to implement evidence-based strategies improving healthcare efficiency and patient outcomes.
- Leadership ability to work with hospitals, NGOs, healthcare startups, and government agencies.
🌍 Creating Future Healthcare Leaders
Doctorials Academy’s vision is to produce ethical, research-driven healthcare managers who can:
- Use epidemiology and data analytics to solve real healthcare challenges.
- Contribute to national health programs, clinical research, and healthcare innovation.
- Bring meaningful changes in community health, ensuring care is equitable, efficient, and evidence-based.
Our PGDHM students are trained not just to manage hospitals — but to lead transformation in the healthcare sector, integrating management, public health, and research.
📚 Join the Change
If you are passionate about making a difference in healthcare, PGDHM at Doctorials Academy is your path to a rewarding, impactful career.
Learn how General Epidemiology and Research Methods can help you shape better policies, manage healthier communities, and contribute to the next wave of healthcare innovation.
Enroll Now | Learn More
🌐 www.doctorialsacademy.com
📧 contact@doctorialsacademy.com
📞 +91-9108962129
Website:- https://doctorialsacademy.com/
PGDHM:- https://doctorialsacademy.com/pgdhm/
LinkedIn:- https://in.linkedin.com/company/doctorials-academy
Facebook:- https://www.facebook.com/people/Doctorials-Academy/61558183675530/
YouTube:- https://www.youtube.com/channel/UCEukyOB7riOSdUhz68tdLzA
Instagram:- https://www.instagram.com/doctorialsacademy/
Android app:- https://play.google.com/store/apps/details?id=com.edmingle.doctorialsacademy&hl=en
